Skip to main content

Wound Care

1
Pipeline Programs
2
Companies
8
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

B. Braun
B. BraunGermany - Melsungen
1 program
1
ProntosanPhase 45 trials
Active Trials
NCT07275307Not Yet Recruiting456Est. Dec 2027
NCT03369756Terminated43Est. Sep 2019
NCT01534858Completed51Est. Jun 2015
+2 more trials
Integra LifeSciences
Integra LifeSciencesAustralia - Clayton
1 program
Integra Dermal Regeneration templateN/A1 trial
Active Trials
NCT05311124Unknown10Est. Oct 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
B. BraunProntosan
B. BraunProntosan
B. BraunProntosan
Integra LifeSciencesIntegra Dermal Regeneration template
B. BraunProntosan
B. BraunProntosan
B. BraunProntosan
B. BraunProntosan

Clinical Trials (8)

Total enrollment: 903 patients across 8 trials

NCT01153633B. BraunProntosan

Trial on the Efficacy of Prontosan Wound Irrigation Solution and Prontosan Wound Gel

Start: Oct 2009Est. completion: Oct 201134 patients
Phase 4Completed
NCT01333670B. BraunProntosan

Efficacy of Prontosan Solution on Chronic Ulcers

Start: Apr 2011Est. completion: Dec 2012289 patients
Phase 3Completed
NCT07275307B. BraunProntosan

Impact of Prontosan Wound Gel X on Surgical Site Infections in Cardiac Surgery

Start: Jan 2026Est. completion: Dec 2027456 patients
N/ANot Yet Recruiting
NCT05311124Integra LifeSciencesIntegra Dermal Regeneration template

Direct Application of Integra Bilayer Matrices on Bare Calvarium Without Preliminary Burring

Start: Aug 2022Est. completion: Oct 202310 patients
N/AUnknown
NCT03369756B. BraunProntosan

Prontosan Quality of Life Study in Patients With Chronic Leg Wound(s)

Start: Feb 2018Est. completion: Sep 201943 patients
N/ATerminated
NCT01554644B. BraunProntosan

Prontosan Versus Saline in the Cleansing of Chronic Leg Ulcers in Diabetic Patients

Start: Mar 2012Est. completion: Oct 20120
N/AWithdrawn
NCT01534858B. BraunProntosan

A Prospective, Descriptive Cohort Study With Prontosan® Wound Gel X in Partial and Full Thickness Burns Requiring Split Thickness Skin Grafts

Start: Mar 2012Est. completion: Jun 201551 patients
N/ACompleted
NCT01048307B. BraunProntosan

Effect of Prontosan Wound Irrigation Solution on Venous Ulcers

Start: Jun 2009Est. completion: Jul 201020 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.